Tapentadol: a new option for the treatment of cancer and noncancer pain

Clicks: 191
ID: 16806
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #50 of 91 articles by views in journal of pain research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Anthony H Dickenson,1 Hans G Kress2 1Neuroscience, Physiology and Pharmacology, University College London, London WC1E6BT, UK; 2Department of Special Anaesthesia and Pain Medicine, Medical University, AKH of Vienna, Vienna, AustriaThe last years have witnessed major advances in the knowledge of the basic mechanisms underlying the onset and the chronification of pain. In particular, it has emerged that pain signaling and modulatory mechanisms change following physiopathological events, such as the two major types of pain, neuropathic and inflammatory pains. Very different chemical events and ion channel changes, respectively, underlie these pains at peripheral levels, so treatments have to differ. Low back pain and cancer pain can be one or the other or a combination of these different mechanisms, so-called mixed pains. The final pain experience is a combination of all these peripheral and central events, but within the central nervous system, the pain controlling systems are more common so that therapies acting on central modulation can span a range of pain conditions. Descending controls link the brain back to the spinal cord, where noradrenaline (NRI) is a key inhibitory transmitter in pain control in these pathways. Descending controls run from the brain to the spinal cord and can be gaged in patients – the balance between excitations and facilitations’ shift to the latter in persistent pain states, reinforcing pain transmission.1
Reference Key
ah2019tapentadoljournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors AH, Dickenson;HG, Kress;
Journal journal of pain research
Year 2019
DOI
DOI not found
URL
https://www.dovepress.com/tapentadol-a-new-option-for-the-treatment-of-cancer-and-noncancer-pain-peer-reviewed-article-JPR
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.